Fig. 3From: Subcellular localisation of pMEK has a different prognosis in locally advanced head and neck cancer treated with concomitant radiochemotherapyImmunostaining for pMEK. a Tumours with absence of pMEK expression (0), b low expression (1),c moderate expression (2), d and high expression (3) in nucleus and cytoplasmBack to article page